Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities

被引:5
|
作者
Briggs, Sarah [1 ]
Slade, Ingrid [2 ,3 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Wellcome Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England
[2] Univ Oxford, Wellcome Ctr Eth & Humanities, Old Rd Campus, Oxford OX3 7LF, England
[3] Univ Oxford, Ethox Ctr, Nuffield Dept Populat Hlth, Big Data Inst,Li Ka Shing Ctr Hlth Informat & Dis, Old Rd Campus, Oxford OX3 7LF, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Cancer; Screening; Cancer genomics; Population health; Genetic susceptibility; Public health; BREAST-CANCER; PROSTATE-CANCER; POLYGENIC RISK; SUSCEPTIBILITY; GENETICS; BRCA1; RECOMMENDATIONS; PREDICTION; EXPERIENCE; MUTATIONS;
D O I
10.1007/s40142-019-00162-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose of ReviewAs the costs of genomic testing have fallen, and our understanding of genetic susceptibility to cancers has grown, there has been increasing interest in incorporating testing for cancer susceptibility genes, and polygenic risk estimates, into population cancer screening. A growing body of evidence suggests that this would be both clinically and cost-effective. In this article, we aim to explore the frameworks used to evaluate screening programmes, evaluate whether population screening for cancer susceptibility can be assessed using these standards, and consider additional issues and outcomes of importance in this context.Recent FindingsThere are tensions between traditional approaches of genetic testing (utilising tests with high sensitivity and specificity) and the principles of population screening (in which the screening test typically has low specificity), as well as the frameworks used to evaluate the two. Despite the existence of many screening guidelines, including consensus papers, these often do not align fully with broader considerations of genetic test evaluation. Population screening for genetic risk in cancer shifts the focus from diagnostics to prognostication and has wider implications for personal and familial health than existing screening programmes. In addition, understanding of the prevalence and penetrance of cancer susceptibility genes, required by many screening guidelines, may only be obtainable through population-level testing; prospective multi-disciplinary research alongside implementation will be essential.SummaryAppropriate evaluation of genetic screening for cancer risk will require modification of existing screening frameworks to incorporate additional complexity of outcomes and population values. As evidence supporting population screening for cancer susceptibility mounts, development of an appropriate evaluative framework, and expansion of public dialogue will be key to informing policy.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 50 条
  • [1] Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities
    Sarah Briggs
    Ingrid Slade
    Current Genetic Medicine Reports, 2019, 7 : 63 - 74
  • [2] Integration of genomics into community-based breeding programmes for chickens: an overview of opportunities, challenges, and potential benefits
    Olaniyan, Olawale F.
    Oladejo, Opeyemi A.
    Adeola, Adeniyi C.
    Bello, Semiu F.
    Bashiru, Hameed A.
    Oseni, Saidu O.
    WORLDS POULTRY SCIENCE JOURNAL, 2024, 80 (03) : 977 - 997
  • [3] Genomics pipelines and data integration: challenges and opportunities in the research setting
    Davis-Turak, Jeremy
    Courtney, Sean M.
    Hazard, E. Starr
    Glen, W. Bailey
    da Silveira, Willian A.
    Wesselman, Timothy
    Harbin, Larry P.
    Wolf, Bethany J.
    Chung, Dongjun
    Hardiman, Gary
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (03) : 225 - 237
  • [4] Opportunities and Challenges in Screening for Colorectal Cancer
    Miller Wilson, Lesley-Ann
    Browne, Sara
    Barnes, Jake
    Hoyek, Nancy El
    Helmueller, Leah
    Joao Janeiro, Maria
    Wendt, Barry
    POPULATION HEALTH MANAGEMENT, 2023, 26 (04) : 246 - 253
  • [5] Bridging the gaps in newborn screening programmes: Challenges and opportunities to detect in Africa
    Twum, Seth
    Fosu, Kwadwo
    Felder, Robin A.
    Sarpong, Kwabena A. N.
    AFRICAN JOURNAL OF LABORATORY MEDICINE, 2023, 12 (01)
  • [6] Of what value Genomics in colorectal cancer? Opportunities and challenges
    Johnston, PG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1538 - 1539
  • [7] Evaluating cervical cancer screening programmes for developing countries
    SherlawJohnson, C
    Gallivan, S
    Jenkins, D
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (02) : 210 - 216
  • [8] Human genomics: Challenges and opportunities
    Tinkle, MB
    Cheek, DJ
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2002, 31 (02): : 178 - 187
  • [9] Structural genomics:: opportunities and challenges
    Mittl, PRE
    Grütter, MG
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 402 - 408
  • [10] Clinical Genomics: Challenges and Opportunities
    Vijay, Priyanka
    McIntyre, Alexa B. R.
    Mason, Christopher E.
    Greenfield, Jeffrey P.
    Li, Sheng
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2016, 26 (02): : 97 - 113